Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Oxybutynin and Solifenacin in the Treatment of Overactive Bladder: a Randomized Controlled Multicenter Trial

NCT01423838 is registered in ClinicalTrials.gov with Adana Numune Training and Research Hospital as lead sponsor.

NCT NCT01423838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01423838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Oxybutynin and Solifenacin in the Treatment of Overactive Bladder: a Randomized Controlled Multicenter Trial
Lead sponsor
Adana Numune Training and Research Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2011
Completion date
September 30, 2012
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder